Institutional Cluster

SRPT

Sarepta Therapeutics, Inc.
MIXED
Impact 4/10
Horizonweeks Processed3mo ago
Institutional cluster: 6 buyers, 5 sellers (mixed)
Actionable Insight ◆ Mixed

The mixed institutional signal offers no clear directional bias. Traders should monitor upcoming earnings or pipeline catalysts for SRPT, as the divergence between passive accumulation and active manager exits may resolve with fundamental news. The recent 13F lag means positions may have already been adjusted.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
SRPT ▲ +50.00% at T+60d
NEUTRAL call ✓ call won +50.00% · α vs SPY +45.60% · entry $15.00 → $22.50
Entry anchored
Jun 11, 10:14 AM ET
via exchange tick
T+1d
+2.07%
call +2.07% · α +1.53%
$15.31
settled 4mo ago
T+5d
+13.07%
call +13.07% · α +12.63%
$16.96
settled 4mo ago
T+20d
+36.80%
call +36.80% · α +34.91%
$20.52
settled 3mo ago
T+60d
+50.00%
call +50.00% · α +45.60%
$22.50
settled 24d ago

Executive Summary

An institutional cluster in SRPT shows 6 buyers (adding $99M) and 5 sellers (reducing $102.8M) in Q3 2025, resulting in a net mixed signal. Buying is dominated by passive/quants like RenTech (+$40.4M) and UBS (+$29.8M), while selling features full exits by Norges Bank and Wellington Management, plus large trims by D.E. Shaw. The divergence suggests active manager skepticism against passive accumulation.

Key Financial Metrics

Direction
mixed
Buy Value
$153.2M
Sell Value
$150.2M
Net Flow
-$3.8M

Institutional Positions

Net institutional flow: -$3.8M

▲ Buyers (6)

InstitutionActionChangePosition ValueValue Δ
FidelityADD+75.4%$277.0K$137.0K
Morgan StanleyADD+31%$37.5M$12.1M
InvescoDOUBLED+242%$16.0M$11.9M
CitadelADD+69.6%$9.9M$4.7M
UBSDOUBLED+297.2%$38.4M$29.8M
RenTechDOUBLED+324.4%$51.1M$40.4M

▼ Sellers (5)

InstitutionActionChangePrev ValueValue Δ
Norges BankEXIT-100%$15.6M-$15.6M
D.E. ShawTRIM-55.2%$76.6M-$37.9M
Wellington Management GroupEXIT-100%$43.3M-$43.3M
Ubs Am, A Distinct Business UnTRIM-41.1%$6.8M-$2.3M
Ameriprise FinancialTRIM-52.9%$7.9M-$3.7M

Key Facts

  • 6 institutional buyers added $99M in SRPT during Q3 2025
  • 5 institutional sellers reduced holdings by $102.8M, including two full exits
  • RenTech more than quadrupled its position, adding $40.4M
  • Wellington Management fully exited a $43.3M position
  • D.E. Shaw trimmed 55% of its stake, selling $37.9M

Financial Impact

Net institutional capital flow was roughly balanced: $99M buying vs $102.8M selling, resulting in a slight net outflow of $3.8M.

institutional ownershipfloat

Risk Factors

  • Continued selling by large active managers could pressure the stock
  • Passive buying may be index-related and not reflect fundamental conviction
  • 13F data is 45 days stale; current positioning may differ significantly

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
39% bullish (33 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-SRPT-2025-Q3
5 reports for SRPT
Performance horizon
Filters
Rows
Reports for SRPT — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$15.89 $18.13▲ +14.10%▲ +10.80%—
Jun 11, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$15.00 $20.52▲ +36.80%▲ +34.91%—
Jun 4, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$15.75 $19.18▲ +21.78%▲ +19.92%—
Apr 24, 2026
22w ago
DEFA14A
NEUTRAL ★ 3/10
$20.89 $16.67▼ −20.18%▼ −25.14%—
Feb 25, 2026
31w ago
8-K
MIXED ★ 7/10
$18.85 $23.75▲ +26.00%▲ +31.24%—
Showing 5 of 5

US Market Status

Market Open — Closes in 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026